{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T10:06:15Z","timestamp":1790071575572,"version":"4.0.1"},"publisher-location":"New York, NY","reference-count":30,"publisher":"Springer US","isbn-type":[{"value":"9781071655467","type":"print"},{"value":"9781071655474","type":"electronic"}],"license":[{"start":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T00:00:00Z","timestamp":1790121600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T00:00:00Z","timestamp":1790121600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2027]]},"DOI":"10.1007\/978-1-0716-5547-4_20","type":"book-chapter","created":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T09:23:17Z","timestamp":1790068997000},"page":"389-409","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Nucleofection-Based CRISPR\/Cas Delivery in Human T Cells for Immunotherapy Applications"],"prefix":"10.1007","author":[{"given":"Mar\u00eda","family":"Ortiz-Bueno","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alejandro","family":"Mill\u00e1n-L\u00f3pez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kornel","family":"Labun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karim","family":"Benabdellah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,9,23]]},"reference":[{"key":"20_CR1","doi-asserted-by":"publisher","first-page":"1361","DOI":"10.1126\/science.aar6711","volume":"359","author":"CH June","year":"2018","unstructured":"June CH, O\u2019Connor RS, Kawalekar OU et al (2018) CAR T cell immunotherapy for human cancer. Science 359:1361\u20131365","journal-title":"Science"},{"key":"20_CR2","doi-asserted-by":"publisher","first-page":"2202","DOI":"10.1016\/j.ymthe.2017.05.024","volume":"25","author":"H Tashiro","year":"2017","unstructured":"Tashiro H, Sauer T, Shum T et al (2017) Treatment of acute myeloid leukemia with T cells expressing chimeric antigen receptors directed to C-type lectin-like molecule 1. Mol Ther 25:2202\u20132213","journal-title":"Mol Ther"},{"key":"20_CR3","first-page":"92","volume":"4","author":"BL Levine","year":"2017","unstructured":"Levine BL, Miskin J, Wonnacott K et al (2017) Global manufacturing of CAR T cell therapy. Mol Ther 4:92\u2013101","journal-title":"Mol Ther"},{"key":"20_CR4","doi-asserted-by":"publisher","first-page":"1354825","DOI":"10.3389\/fimmu.2024.1354825","volume":"15","author":"R Tao","year":"2024","unstructured":"Tao R, Han X, Bai X et al (2024) Revolutionizing cancer treatment: enhancing CAR-T cell therapy with CRISPR\/Cas9 gene editing technology. Front Immunol 15:1354825","journal-title":"Front Immunol"},{"key":"20_CR5","doi-asserted-by":"publisher","first-page":"2517","DOI":"10.1038\/s41375-024-02444-y","volume":"38","author":"T Lei","year":"2024","unstructured":"Lei T, Wang Y, Zhang Y et al (2024) Leveraging CRISPR gene editing technology to optimize the efficacy, safety and accessibility of CAR T-cell therapy. Leukemia 38:2517\u20132543","journal-title":"Leukemia"},{"key":"20_CR6","doi-asserted-by":"publisher","first-page":"3066","DOI":"10.1002\/btpr.3066","volume":"37","author":"E Harris","year":"2021","unstructured":"Harris E, Elmer JE (2021) Optimization of electroporation and other non-viral gene delivery strategies for T cells. Biotechnol Progress 37:3066","journal-title":"Biotechnol Progress"},{"key":"20_CR7","doi-asserted-by":"publisher","first-page":"985","DOI":"10.1084\/jem.20171626","volume":"215","author":"A Seki","year":"2018","unstructured":"Seki A, Rutz S (2018) Optimized RNP transfection for highly efficient CRISPR\/Cas9-mediated gene knockout in primary T cells. J Exp Med 215:985\u2013997","journal-title":"J Exp Med"},{"key":"20_CR8","doi-asserted-by":"publisher","first-page":"2401632","DOI":"10.1002\/smtd.202401632","volume":"10","author":"F Wu","year":"2026","unstructured":"Wu F, Ni L, Xiao Y et al (2026) Lipid nanoparticles for delivery of CRISPR gene editing components. Small Methods 10:2401632","journal-title":"Small Methods"},{"key":"20_CR9","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-023-33941-2","volume":"13","author":"JA VanderBurgh","year":"2023","unstructured":"VanderBurgh JA, Corso TN, Levy SL et al (2023) Scalable continuous-flow electroporation platform enabling T cell transfection for cellular therapy manufacturing. Sci Rep 13: 6857","journal-title":"Sci Rep"},{"key":"20_CR10","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2021\/6644685","volume":"2021","author":"V Lukjanov","year":"2021","unstructured":"Lukjanov V, Koutn\u00e1 I, \u0160imara P (2021) CAR T-cell production using nonviral approaches. J Immunol Res 2021:1\u20139","journal-title":"J Immunol Res"},{"key":"20_CR11","doi-asserted-by":"publisher","DOI":"10.1186\/s12951-024-02630-1","volume":"22","author":"MB Khawar","year":"2024","unstructured":"Khawar MB, Afzal A, Si Y et al (2024) Steering the course of CAR T cell therapy with lipid nanoparticles. J Nanobiotechnol 22: 380","journal-title":"J Nanobiotechnol"},{"key":"20_CR12","doi-asserted-by":"publisher","first-page":"3750","DOI":"10.1182\/blood-2014-01-552174","volume":"123","author":"Y Xu","year":"2014","unstructured":"Xu Y, Zhang M, Ramos AM et al (2014) Closely related T-memory stem cells correlate with in vivo expansion of CAR.CD19-T cells and are preserved by IL-7 and IL-15. Blood 123:3750\u20133759","journal-title":"Blood"},{"key":"20_CR13","doi-asserted-by":"publisher","first-page":"1216","DOI":"10.1038\/s41591-018-0137-0","volume":"24","author":"CA Vakulskas","year":"2018","unstructured":"Vakulskas CA, Dever DP, Rettig GR et al (2018) A high-fidelity Cas9 mutant delivered as a ribonucleoprotein complex enables efficient gene editing in human hematopoietic stem and progenitor cells. Nat Med 24:1216\u20131224","journal-title":"Nat Med"},{"key":"20_CR14","doi-asserted-by":"publisher","first-page":"1290","DOI":"10.1038\/nm.2446","volume":"17","author":"L Gattinoni","year":"2011","unstructured":"Gattinoni L, Lugli E, Ji Y et al (2011) A human memory T cell subset with stem cell\u2013like properties. Nat Med 17:1290\u20131297","journal-title":"Nat Med"},{"key":"20_CR15","doi-asserted-by":"publisher","first-page":"3853","DOI":"10.1158\/0008-5472.CAN-14-3321","volume":"75","author":"L Poirot","year":"2015","unstructured":"Poirot L, Philip B, Schiffer-Mannioui C et al (2015) Multiplex genome-edited T-cell manufacturing platform for \u201cOff-the-Shelf\u201d adoptive T-cell immunotherapies. Cancer Res 75:3853\u20133864","journal-title":"Cancer Res"},{"key":"20_CR16","doi-asserted-by":"publisher","first-page":"2255","DOI":"10.1158\/1078-0432.CCR-16-1300","volume":"23","author":"J Ren","year":"2017","unstructured":"Ren J, Liu X, Fang C et al (2017) Multiplex genome editing to generate universal CAR T cells resistant to PD1 inhibition. Clin Cancer Res 23:2255\u20132266","journal-title":"Clin Cancer Res"},{"key":"20_CR17","doi-asserted-by":"publisher","unstructured":"Labun K, Rio O, Tjeldnes H et al (2025) CHOPOFF: symbolic alignments enable fast and sensitive CRISPR off-target detection. bioRxiv 2025.01.06.603201. https:\/\/doi.org\/10.1101\/2025.01.06.603201","DOI":"10.1101\/2025.01.06.603201"},{"key":"20_CR18","doi-asserted-by":"publisher","first-page":"387","DOI":"10.3390\/genes16040387","volume":"16","author":"Y Zheng","year":"2025","unstructured":"Zheng Y, Zou Q, Li J et al (2025) CRISPR-MFH: a lightweight hybrid deep learning framework with multi-feature encoding for improved CRISPR-Cas9 off-target prediction. Genes 16:387","journal-title":"Genes"},{"key":"20_CR19","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1093\/nar\/gkm306","volume":"35","author":"A Untergasser","year":"2007","unstructured":"Untergasser A, Nijveen H, Rao X et al (2007) Primer3Plus, an enhanced web interface to Primer3\u2019. Nucleic Acids Res 35:71\u201374","journal-title":"Nucleic Acids Res"},{"key":"20_CR20","doi-asserted-by":"publisher","first-page":"7365","DOI":"10.1126\/science.aba7365","volume":"367","author":"EA Stadtmauer","year":"2020","unstructured":"Stadtmauer EA, Fraietta J, Davis MM et al (2020) CRISPR-engineered T cells in patients with refractory cancer. Science 367:7365","journal-title":"Science"},{"key":"20_CR21","unstructured":"FDA (2024) Human Gene Therapy Products Incorporating Human Genome Editing; Guidance for Industry. https:\/\/www.fda.gov\/regulatory-information\/search-fda-guidance-documents\/human-gene-therapy-products-incorporating-human-genome-editing. Accessed 29 April 2026"},{"issue":"11","key":"20_CR22","doi-asserted-by":"publisher","first-page":"1317","DOI":"10.1038\/s41587-020-0555-7","volume":"38","author":"CR Lazzarotto","year":"2020","unstructured":"Lazzarotto CR, Malinin NL, Li Y et al (2020) CHANGE-seq reveals genetic and epigenetic effects on CRISPR\u2013Cas9 genome-wide activity. Nat. Biotechnol. 38(11):1317\u20131327","journal-title":"Nat. Biotechnol."},{"key":"20_CR23","doi-asserted-by":"publisher","first-page":"673022","DOI":"10.3389\/fgeed.2021.673022","volume":"3","author":"A Atkins","year":"2021","unstructured":"Atkins A, Chung C, Allen AG et al (2021) Off-target analysis in gene editing and applications for clinical translation of CRISPR\/Cas9 in HIV-1 therapy. Front Genome Ed 3:673022","journal-title":"Front Genome Ed"},{"key":"20_CR24","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1038\/nbt.3117","volume":"33","author":"SQ Tsai","year":"2015","unstructured":"Tsai SQ, Zheng Z, Nguyen NT et al (2015) GUIDE-seq enables genome-wide profiling of off-target cleavage by CRISPR-Cas nucleases. Nat Biotechnol 33:187\u2013197","journal-title":"Nat Biotechnol"},{"key":"20_CR25","doi-asserted-by":"publisher","first-page":"286","DOI":"10.1126\/science.aav9023","volume":"364","author":"B Wienert","year":"2019","unstructured":"Wienert B, Wyman SK, Richardson CK et al (2019) Unbiased detection of CRISPR off-targets in vivo using DISCOVER-Seq. Science 364:286\u2013289","journal-title":"Science"},{"key":"20_CR26","doi-asserted-by":"publisher","first-page":"1136","DOI":"10.1016\/j.stem.2021.02.002","volume":"28","author":"G Turchiano","year":"2021","unstructured":"Turchiano G, Andrieux G, Klermund J et al (2021) Quantitative evaluation of chromosomal rearrangements in gene-edited human stem cells by CAST-Seq. Cell Stem Cell 28:1136\u20131147","journal-title":"Cell Stem Cell"},{"key":"20_CR27","doi-asserted-by":"publisher","DOI":"10.1186\/s12864-018-4561-9","volume":"19","author":"G Giannoukos","year":"2018","unstructured":"Giannoukos G, Ciulla DM, Marco E et al (2018) UDiTaSTM, a genome editing detection method for indels and genome rearrangements. BMC Genomics 19: 212","journal-title":"BMC Genomics"},{"key":"20_CR28","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1038\/s41421-019-0088-8","volume":"5","author":"J Yin","year":"2019","unstructured":"Yin J, Liu M, Liu Y et al (2019) Optimizing genome editing strategy by primer-extension-mediated sequencing. Cell Discov 5:18","journal-title":"Cell Discov"},{"key":"20_CR29","doi-asserted-by":"publisher","first-page":"2618","DOI":"10.1021\/ac403843j","volume":"86","author":"L Miotke","year":"2014","unstructured":"Miotke L, Lau BT, Rumma RT et al (2014) High sensitivity detection and quantitation of DNA copy number and single nucleotide variants with single color droplet digital PCR. Anal Chem 86:2618\u20132624","journal-title":"Anal Chem"},{"issue":"4","key":"20_CR30","doi-asserted-by":"publisher","first-page":"153901","DOI":"10.1371\/journal.pone.0153901","volume":"11","author":"SD Findlay","year":"2016","unstructured":"Findlay SD, Vincent KM, Berman JR et al (2016) A digital PCR-based method for efficient and highly specific screening of genome edited cells. PLoS ONE 11(4):153901","journal-title":"PLoS ONE"}],"container-title":["Methods in Molecular Biology","CRISPR Delivery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/978-1-0716-5547-4_20","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T09:23:21Z","timestamp":1790069001000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/978-1-0716-5547-4_20"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,23]]},"ISBN":["9781071655467","9781071655474"],"references-count":30,"URL":"https:\/\/doi.org\/10.1007\/978-1-0716-5547-4_20","relation":{},"ISSN":["1064-3745","1940-6029"],"issn-type":[{"value":"1064-3745","type":"print"},{"value":"1940-6029","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,23]]},"assertion":[{"value":"23 September 2026","order":1,"name":"first_online","label":"First Online","group":{"name":"ChapterHistory","label":"Chapter History"}},{"value":"The authors declare no conflicts of interest and were guided by literature and conference evidence in content choices and conclusions. The funders had no role in the design of the study; in the collection, analyses, or interpretation of data; in the writing of the manuscript; or in the decision to publish the results.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing Interests"}}]}}